All News

More than a quarter of tested patients with non-small cell lung cancer responded to Amtagvi monotherapy.

Specialized sarcoma centers enhance coordinated care for young adults, although travel and financial barriers persist, Dr. Vinayak Venkataraman stated.

This year’s Breast Cancer Awareness Month highlighted FDA approvals, survivorship challenges and advances in breast reconstruction.

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

Long-awaited progress in rectal and gastric cancer research includes a fast track designation and new survival data.

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

A young cancer survivor who underwent external beam radiation therapy and brachytherapy at 14 years old discusses her rare diagnosis, side effects and the nonlink to her Turner syndrome.

The U.S. FDA has granted orphan drug designation to M2T-CD33 for the treatment of patients with acute myeloid leukemia.

This is an essential guide on stage 2 cervical cancer to support patients in discussing diagnosis, treatment, and care decisions with their oncology team.

LiveLung invites the CSRA’s lung cancer community to its educational meeting.

LiveLung invites the Charlotte lung cancer community to its monthly educational meeting.

LiveLung invites the community to its monthly Small Cell Lung Cancer (SCLC) virtual educational meeting.

Learn how HR-positive/HER2-negative breast cancer is diagnosed, treated by stage and managed for side effects to guide patient-oncologist discussions.

An 11-year survivor of stage 4 breast cancer explains that everyone has a role to play.

CURE spoke with an areola tattoo artist and a patient who has undergone the procedure.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.

A cancer survivor explains how humor helped her during her cancer journey.

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults.

In October 2025, the FDA granted approval to multiple new cancer therapies and supportive care options, covering treatments across the oncologic landscape.

In honor of Pancreatic Cancer Awareness Month, we spoke with Dr. Rosario Ligresti about rising rates of the disease in younger adults and more.

I share how walking has helped me through lymphoma, knee surgeries and treatments, and why staying active keeps me physically, mentally and spiritually strong.

Stoboclo and Osenvelt is now interchangeable with brand-name drugs, per the FDA, letting pharmacists substitute them while ensuring safety and efficacy.

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early.

Choosing treatment for stage 2 prostate cancer? Get the facts on surgery versus radiation and learn to manage possible side effects such as erectile dysfunction.

Tamron Little was diagnosed with peritoneal mesothelioma after childbirth and now, 18 years later, she says survivorship is lifelong.

LiveLung invites the Wilmington community to its monthly educational meeting.